Clariden Investment Overview

  • Investor Type
  • Venture Capital
  • Status
  • Inactive
  • Investments
  • 7
  • Exits
  • 4
Exits

Clariden Investment General Information

Description

Clariden Investment was a venture capital firm that preferred to invest in the biotechnology sector.

Contact Information

Investor Status
Out of Business
Primary Investor Type
Venture Capital
Primary Office
  • Switzerland

Clariden Investment Investments (7)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Santhera Pharmaceuticals 01-Oct-2006 Early Stage VC 0000 Biotechnology Generating Revenue/Not Profitable
00000000 000000000 01-Jan-2005 00000 00000 000.00 Biotechnology Generating Revenue/Not Profitable
00000 000000000000 17-Aug-2004 00000 00000 0000 Drug Delivery Profitable
00000 000000000000 25-May-2004 00000 00000 0000 Biotechnology Out of Business
00000000 30-Mar-2004 00000 00000 0000 Drug Discovery Clinical Trials - Phase 2
Altus Pharmaceuticals 26-Dec-2001 Later Stage VC 000.00 Biotechnology Out of Business
CyDex Pharmaceuticals 11-Oct-2000 Early Stage VC 0000 Drug Delivery Profitable
To view Clariden Investment’s complete investments history, request access »
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Clariden Investment Exits (4)

Company Name Exit Date Exit Type Exit Size
CyDex Pharmaceuticals 26-Jan-2011 Merger/Acquisition 000.00
00000000 000000000 03-Nov-2006 000 000.00
Altus Pharmaceuticals 26-Jan-2006 IPO 00000
Salmedix 14-Jun-2005 Merger/Acquisition 00000
To view Clariden Investment’s complete exits history, request access »

Clariden Investment Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial